#FDA booster shot


FDA panel rejects plan for wide access to Covid vaccine booster shots, but approves them for older Americans

An advisory panel to the US Food and Drug Administration has rejected a Biden administration proposal to offer booster Pfizer Covid shots to most Americans, but approved their use for elderly or at-risk patients.In a vote of 16 to two on Friday, the panel of outside experts decided against the plan for widespread boosters, citing insufficient data on the safety or necessity of the third shots. However, in a second vote, the experts voted unanimously in favor of administering the boosters to Americans aged 65 or over, and to those at high risk of severe disease.The FDA itself has...

Lane County health experts weigh in on FDA booster shot decision

LANE COUNTY, Ore. -- A decision made by an advisory committee for the Food and Drug Administration could allow people 65 and older to get a booster shot. KEZI 9 News spoke to local health officials about whether they agree with this decision. Dr. Patrick Luedtke with Lane County Public Health said he believes there is not enough data for him to be comfortable with full FDA approval of a booster shot for all.
WWLP 22News

FDA to discuss Pfizer’s third “booster” shot potential this week

SPRINGFIELD, Mass. (WWLP) – The Food and Drug Administration (FDA) will meet to discuss Pfizer’s application for a third “booster” dose of the COVID-19 vaccine in people 16 and older who are not immunocompromised on September 17th. “A booster would give a little jump to the immune system to say,...

FDA Advisors Reject Widespread Pfizer COVID-19 Booster Shots Plan

WASHINGTON (AP) — An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe disease. The twin votes Friday represented a...

Federal Health Officials Want The White House To Slow Its COVID Booster Shot Rollout

The leaders of two federal health agencies are urging the White House to rethink its plan to roll out COVID-19 vaccine boosters starting Sept. 20. The leaders of the Food and Drug Administration and the Centers for Disease Control and Prevention are telling White House COVID-19 advisers that there is not enough data right now to make a blanket recommendation on boosters and that it may be prudent to start boosters with older adults first, pending FDA authorization. That's according to a source who has knowledge of the situation but is not authorized to speak publicly.